341 related articles for article (PubMed ID: 33249080)
1. In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma.
Chen H; Sa G; Li L; He S; Wu T
Eur J Pharmacol; 2021 Jan; 891():173757. PubMed ID: 33249080
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ROS/NUPR1-dependent autophagy antagonises repeated cadmium exposure -induced oral squamous cell carcinoma cell migration and invasion.
Fan T; Chen Y; He Z; Wang Q; Yang X; Ren Z; Zhang S
Toxicol Lett; 2019 Oct; 314():142-152. PubMed ID: 31319114
[TBL] [Abstract][Full Text] [Related]
4. Galectin‑3 blockade suppresses the growth of cetuximab‑resistant human oral squamous cell carcinoma.
Yin P; Cui S; Liao X; Yao X
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34328195
[TBL] [Abstract][Full Text] [Related]
5. Combined inhibition of RNA polymerase I and mTORC1/2 synergize to combat oral squamous cell carcinoma.
Shi S; Luo H; Wang L; Li H; Liang Y; Xia J; Wang Z; Cheng B; Huang L; Liao G; Xu B
Biomed Pharmacother; 2021 Jan; 133():110906. PubMed ID: 33190037
[TBL] [Abstract][Full Text] [Related]
6. Targeting of Survivin Pathways by YM155 Inhibits Cell Death and Invasion in Oral Squamous Cell Carcinoma Cells.
Zhang W; Liu Y; Li YF; Yue Y; Yang X; Peng L
Cell Physiol Biochem; 2016; 38(6):2426-37. PubMed ID: 27287458
[TBL] [Abstract][Full Text] [Related]
7. pERK-mediated IL8 secretion can enhance the migration, invasion, and cisplatin resistance of CD10-positive oral cancer cells.
Pu Y; Li Q; Wang Y; Xu L; Qiao Q; Guo Y; Guo C
BMC Cancer; 2021 Dec; 21(1):1283. PubMed ID: 34847866
[TBL] [Abstract][Full Text] [Related]
8. Combined Use of Metformin and Everolimus Is Synergistic in the Treatment of Breast Cancer Cells.
Wang Y; Wei J; Li L; Fan C; Sun Y
Oncol Res; 2014; 22(4):193-201. PubMed ID: 26351208
[TBL] [Abstract][Full Text] [Related]
9. Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells.
Wang Y; Zhang Y; Feng X; Tian H; Fu X; Gu W; Wen Y
Oncol Rep; 2021 Mar; 45(3):1249-1260. PubMed ID: 33650651
[TBL] [Abstract][Full Text] [Related]
10. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
11. Propranolol inhibits cell viability and expression of the pro-tumorigenic proteins Akt, NF-ĸB, and VEGF in oral squamous cell carcinoma.
Shibuya CM; Tjioe KC; Oliveira SHP; Bernabé DG
Arch Oral Biol; 2022 Apr; 136():105383. PubMed ID: 35240444
[TBL] [Abstract][Full Text] [Related]
12. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
Harada K; Ferdous T; Harada T; Ueyama Y
Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058
[TBL] [Abstract][Full Text] [Related]
13. Triptolide suppresses oral cancer cell PD-L1 expression in the interferon-γ-modulated microenvironment in vitro, in vivo, and in clinical patients.
Kuo CS; Yang CY; Lin CK; Lin GJ; Sytwu HK; Chen YW
Biomed Pharmacother; 2021 Jan; 133():111057. PubMed ID: 33378962
[TBL] [Abstract][Full Text] [Related]
14. [Effect and mechanism of circular RNA BICD2 on the biological behavior of oral squamous cell carcinoma cells].
Zhang YJ; Zhu QQ; Zhou HX; Wang HY; Zhou H
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Nov; 56(11):1098-1108. PubMed ID: 34763405
[No Abstract] [Full Text] [Related]
15. Combined class I histone deacetylase and mTORC1/C2 inhibition suppresses the initiation and recurrence of oral squamous cell carcinomas by repressing SOX2.
Liang X; Deng M; Zhang C; Ping F; Wang H; Wang Y; Fan Z; Ren X; Tao X; Wu T; Xu J; Cheng B; Xia J
Cancer Lett; 2019 Jul; 454():108-119. PubMed ID: 30981761
[TBL] [Abstract][Full Text] [Related]
16. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
[TBL] [Abstract][Full Text] [Related]
17. [The inhibitory effect of metformin on oral squamous cell carcinoma].
Wang L; Wang Z; Zhao X; Ji N; Zhou Y; Li J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Jun; 50(6):360-5. PubMed ID: 26359040
[TBL] [Abstract][Full Text] [Related]
18. [Effect of circular RNA hsa_circ_0063772 on proliferation, migration and invasion of oral squamous cell carcinoma cells].
Wang F; Wang YF; Su W; Yang HJ; Yang HY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Aug; 54(8):561-567. PubMed ID: 31378036
[No Abstract] [Full Text] [Related]
19. Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression.
Duan W; Chen K; Jiang Z; Chen X; Sun L; Li J; Lei J; Xu Q; Ma J; Li X; Han L; Wang Z; Wu Z; Wang F; Wu E; Ma Q; Ma Z
Cancer Lett; 2017 Jan; 385():225-233. PubMed ID: 27773749
[TBL] [Abstract][Full Text] [Related]
20. circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway.
Peng QS; Cheng YN; Zhang WB; Fan H; Mao QH; Xu P
Cell Death Dis; 2020 Feb; 11(2):112. PubMed ID: 32041942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]